Plain-English translation of NCT04144725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →Researchers are studying whether blood tests called troponins can help doctors quickly and accurately rule out heart disease in patients who are suspected of having it. The study will compare these blood test results with imaging scans of the heart and follow participants for at least 12 months to see how well the blood tests predict heart problems.
Currently, doctors use imaging scans to diagnose heart disease, but these tests take time and aren't always available immediately. This study hopes to show that blood tests alone might help doctors quickly identify which patients truly have heart disease and which patients are safe to go home, potentially speeding up care and reducing unnecessary procedures.
Before your scheduled heart imaging scan, you will have a blood sample drawn to measure certain heart enzymes called troponins. After your imaging scan, researchers will compare your blood test results with your scan results. You will then be contacted periodically over the next 12 months to check on your health and ask about any heart-related symptoms or events you may have experienced.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Norway
Collaborators
Haukeland University Hospital
Enrollment target
~1,000 participants
Started
October 2019
Primary completion
December 2023
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.